Results 121 to 130 of about 10,060 (149)
Some of the next articles are maybe not open access.

Canakinumab in gout

Expert Opinion on Biological Therapy, 2012
Gout is a painful inflammatory arthritis with a prevalence of approximately 4% in the United States, affecting an estimated 8.3 million adults. The past 20 years have shown significant increases in the number of patients with gout and its incidence may still be increasing.
Naomi Schlesinger
exaly   +3 more sources

Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever.

Rheumatology, 2023
Emil Aliyev   +2 more
exaly  

Home - About - Disclaimer - Privacy